Racial disparities and factors associated with prescription for smoking cessation medications among smokers receiving routine clinical care for HIV.

AIDS Care
Cosmas M ZyamboGreer A Burkholder

Abstract

Factors associated with prescription of smoking cessation medication (SCM), including the impact of race, have not been well described among a large population of people living with HIV (PLWH) engaged in routine clinical care. Our study investigated whether there are racial differences between African-American and White PLWH regarding SCM prescription and sought to identify other factors associated with these prescriptions at a large HIV clinic in the Southeastern United States. Among 1899 smokers, 38.8% of those prescribed SCMs were African-American and 61.2% were White. Factors associated with lower odds of SCM prescription included African-American race (AOR, 0.63 [95% CI: 0.47, 0.84]) or transferring care from another HIV provider during the study period (AOR, 0.63 [95% CI: 0.43, 0.91]). Whereas major depression (AOR, 1.54 [95% CI: 1.10, 2.15]), anxiety symptoms (AOR, 1.43 [95% CI: 1.05, 1.94]), and heavy smoking (>20 cigarettes/day) (OR, 3.50 [95% CI: 2.11, 5.98]) were associated with increased likelihood of SCM prescription. There were racial disparities in the prescription of SCM in African Americans with HIV. These findings underscore the need to increase pharmacotherapy use among African Americans to improve smoking ce...Continue Reading

References

Jul 1, 1994·American Journal of Public Health·D L PatrickS Kinne
May 26, 1999·American Journal of Epidemiology·P KissingerD H Martin
Mar 28, 2003·American Journal of Public Health·Kimberly S H YarnallJ Lloyd Michener
Aug 28, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ray Y ChenMichael S Saag
Oct 30, 2004·American Journal of Public Health·Gary KingSunny B Nahata
May 26, 2005·American Journal of Public Health·Thomas K HoustonPaul G Greene
Aug 9, 2005·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Jack E BurkhalterBruce D Rapkin
Feb 10, 2006·Substance Use & Misuse·Patricia DazaDavid W Wetter
Aug 1, 2006·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Frank J PalellaUNKNOWN HIV Outpatient Study Investigators
Oct 13, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Jamie L StudtsRenato V LaRocca
Jul 27, 2007·AIDS Patient Care and STDs·Antoine BenardUNKNOWN Groupe d'Epidemiologie Clinique du SIDA en Aquitaine (GECSA)
Oct 19, 2007·Medical Care Research and Review : MCRR·Marshall H ChinElbert S Huang
Dec 14, 2007·Alcoholism, Clinical and Experimental Research·Molly M KodlAnne Marie Joseph
Jan 19, 2008·American Journal of Preventive Medicine·Saul ShiffmanJoseph G Gitchell
Feb 2, 2008·International Review of Psychiatry·Stephen J Ferrando, Zachary Freyberg
Jun 17, 2008·Clinical Therapeutics·Gisela I RoblesHoytin Lee Ghin
Sep 9, 2008·AIDS and Behavior·James M TesorieroHoward E Lavigne
Feb 6, 2009·Journal of General Internal Medicine·Kathryn A PaezLisa A Cooper
Feb 28, 2009·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Sarah Connor GorberMark Tremblay
Aug 27, 2009·CA: a Cancer Journal for Clinicians·Richard D HurtDavid D McFadden
Nov 5, 2010·Patient Preference and Adherence·Jon O EbbertRichard D Hurt
Sep 8, 2011·Behavioral Medicine·Diana W StewartKyle S Minor
Nov 2, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Michael S KozakJames H Willig
Sep 4, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Greer A BurkholderJames H Willig
Apr 11, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Daniel K ShirleyMarshall J Glesby
Jun 5, 2013·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Nicole L NollenLisa Sanderson Cox
Dec 25, 2013·PloS One·Hasina SamjiUNKNOWN North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA
Feb 15, 2014·BMJ : British Medical Journal·Gemma TaylorPaul Aveyard
Jan 15, 2016·Journal of AIDS & Clinical Research·Cosmas M ZyamboGreer A Burkholder
Nov 7, 2016·The Journal of Infectious Diseases·Krishna P ReddyRochelle P Walensky
Mar 9, 2017·Preventive Medicine Reports·Maya VijayaraghavanJason Satterfield
May 16, 2017·The Lancet. HIV·Ingrid T Katz, Brendan Maughan-Brown

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy

Software Mentioned

MS SQL Server
SPSS Statistics

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.